SEC Comment Letter for Applied Molecular Transport Inc. (CIK 0001801777) — Mar 15, 2022
Applied Molecular Transport Inc. (CIK 0001801777)
Date: March 15, 2022 · CIK: 0001801777 · Accession: 0000000000-22-002856
AI Filing Summary & Sentiment
File numbers found in text: 333-263501
Letter
United States securities and exchange commission logo March 15, 2022 Tahir Mahmood, PhD Chief Executive Officer Applied Molecular Transport Inc. 450 East Jamie Court South San Francisco, California 94080 Re:Applied Molecular Transport Inc. Registration Statement on Form S-3 Filed March 11, 2022 File No. 333-263501 Dear Mr. Mahmood: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael Coke, Esq.
Show Raw Text
United States securities and exchange commission logo
March 15, 2022
Tahir Mahmood, PhD
Chief Executive Officer
Applied Molecular Transport Inc.
450 East Jamie Court
South San Francisco, California 94080
Re:Applied Molecular Transport Inc.
Registration Statement on Form S-3
Filed March 11, 2022
File No. 333-263501
Dear Mr. Mahmood:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael Coke, Esq.